Background As the most widespread mRNAs modification, N6‐methyladenosine (m6A) is
dynamically and reversibly modulated by methyltransferases and demethylases. ALKBH5 is …

Abstract N6-methyladenosine (m6A) modification plays a crucial role in the progression of
osteoporosis (OP). The study aimed to explore the effects of methyltransferase-like 3 …

Abstract Rationale: Osteosarcoma (OS), the most common type of bone tumor, which
seriously affects the patients' limb function and life quality. OS has a strong tendency of lung …

Abstract N6-methyladenosine (m< sup> 6</sup> A) is the most common internal reversible
modification of mRNA, which occurs on the N< sup> 6</sup> nitrogen of adenosine. Fat …

Although many studies have confirmed the relationship between obesity and endometrial
cancer (EC), the molecular mechanism between obesity and EC progression has not been …

ABSTRACT N6-methyladenosine (m6A) modification, the most abundant internal
methylation of eukaryotic RNA transcripts, is critically implicated in RNA processing. There is …

The progression of numerous malignancies has been linked to N6-methyladenosine (m6A)
alteration. However, the opposite trend of m6A levels in the development and metastasis of …

Osteosarcoma (OS) is a type of primary malignant cancer occurring in the bone and poses a
threat to the lives of children and young adults. Long non‑coding RNAs (lncRNAs) have …

Ewing's sarcoma has a poor prognosis and high metastasis rate; thus, it is critical to explore
prognostic biomarkers of m6A-related genes. Two datasets were downloaded from the Gene …

Doxorubicin and platinum are widely used in the frontline treatment of osteosarcoma, but
resistance to chemotherapy limits its curative effect. Here, we have identified that METTL1 …